v3.26.1
COMMITMENTS AND CONTINGENCIES (Details Narrative) - USD ($)
1 Months Ended 6 Months Ended 12 Months Ended
May 23, 2025
Jun. 30, 2026
Jun. 30, 2025
Dec. 31, 2025
Aug. 27, 2025
Jun. 01, 2025
Exercise price   $ 0.29        
Total estimated fair value of the conversion feature   $ 326,000   $ 548,000    
Gain   $ 222,000        
Number of warrants issued   1,500,000        
Operating lease cost   $ 84,000 $ 55,000      
Cash paid for the operating lease liability   $ 50,000 $ 59,000      
Stock price   $ 0.29        
Warrants to purchase shares   4,000,000        
Increase in operating lease liability and ROU asset   $ 642,000        
Exercise price   $ 0.40        
Additional warrant to purchase   2,000,000        
Exercise price of additional warrants   $ 0.25        
Compensation expense       270,000    
50 LuViva devices [Member]            
Purchase commitment amount receive   $ 300,000        
Purchased description   50 LuViva devices and 500,000 single-use components upon approval of LuViva by NMPA        
35 LuViva devices [Member]            
Purchase commitment amount receive   $ 200,000        
Total amount recevie as purchase commitment   $ 700,000        
Number of warrants issued   2,500,000        
Four LuViva devices [Member]            
Purchase commitment amount receive   $ 80,000        
Dr. Faupel's            
Exercise price         $ 0.25  
Conversion price   $ 0.25        
Deferred compensation   $ 557,000   473,000    
Deferred salary $ 374,000         $ 100,000
Increase in officers compensation $ 240,000          
Compensation expense       $ 548,000    
Black-Scholes option Pricing Model [Member]            
Volatility   171.90%        
Risk-free interest rate   3.98% 4.00%      
Expected term (years)   1 year 3 months 18 days 3 years      
Exercise price   $ 0.25        
Stock price   $ 0.24        
Consulting Agreement [Member] | Ironstone capital corp and Alan Grujic            
Monthly payment   $ 2,500,000        
Expense   $ 15,000 $ 15      
Agreement Smi Fund [Member]            
Deferred revenue     $ 184,000